ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

HRTX Heron Therapeautics Inc

2.50
0.16 (6.84%)
May 02 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,501,408
Bid Price 2.50
Ask Price 2.71
News -
Day High 2.55

Low
0.50

52 Week Range

High
3.22

Day Low 2.335
Share Name Share Symbol Market Stock Type
Heron Therapeautics Inc HRTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.16 6.84% 2.50 19:00:00
Open Price Low Price High Price Close Price Previous Close
2.39 2.335 2.55 2.55 2.34
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
6,131 1,501,408 US$ 2.44 US$ 3,664,435 - 0.50 - 3.22
Last Trade Type Quantity Price Currency
17:28:25 10 US$ 2.55 USD

Heron Therapeautics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
383.34M 150.33M - 127.04M -110.56M -0.74 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Heron Therapeautics News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HRTX Message Board. Create One! See More Posts on HRTX Message Board See More Message Board Posts

Historical HRTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.662.662.272.432,174,482-0.16-6.02%
1 Month2.623.1452.272.682,038,838-0.12-4.58%
3 Months2.263.222.212.752,287,3970.2410.62%
6 Months0.6333.220.502.053,006,4161.87294.94%
1 Year2.433.220.501.722,588,2310.072.88%
3 Years17.7018.800.504.482,374,999-15.20-85.88%
5 Years17.8526.8580.507.571,844,289-15.35-85.99%

Heron Therapeautics Description

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Your Recent History

Delayed Upgrade Clock